0000950170-25-105378
SEC filingRevenue grew 35.3% YoY in Q2 2025 driven by organic growth across all end markets, while operating margin compressed due to higher G&A costs.
For the three months ended June 30, 2025, revenue increased 35.3% to $115.1 million compared to $85.0 million in the prior-year period, driven by organic growth across all three end markets. Gross profit rose 35.9% to $47.0 million, with gross margin improving slightly to 40.9% from 40.7%, benefiting from operating leverage. Operating income grew 10.0% to $20.1 million, but operating margin declined to 17.5% from 21.5% as general and administrative expenses surged 94.4% to $19.4 million, reflecting higher compensation, professional fees related to public company operations, and acquisition integration costs. Net income increased 47.8% to $6.8 million, with net income margin up to 5.9% from 5.4%, helped by lower interest expense. GAAP EPS was $0.05 versus $0.03 in the prior year. Adjusted EBITDA grew 28.6% to $35.3 million, while Adjusted EBITDA margin contracted to 30.7% from 32.2%.
For the six-month period, revenue grew 28.1% to $215.2 million, gross margin expanded 240 bps to 40.2%, but net income declined 70.1% to $2.0 million due to a significant increase in G&A (up 112.7%) and a higher tax provision. Operating margin fell to 14.0% from 18.9%.
Revenue by end market in Q2 2025: Hypersonics and Strategic Missile Defense grew 21.6% to $35.0 million, driven by the Next Generation Interceptor program and classified programs. Space and Launch increased 38.9% to $39.6 million, supported by higher launch cadence and demand for critical subsystems. Tactical Missiles and Integrated Defense Systems rose 45.9% to $40.5 million, reflecting production growth in UAS and non-UAS programs. This segment remained the largest and fastest-growing, benefiting from successful system deployments and continued investment in next-generation capabilities.
Management did not provide quantitative guidance but highlighted positive tailwinds from the One Big Beautiful Bill Act, which includes approximately $150 billion in incremental defense funding through FY 2029 for hypersonics, missiles, and munitions. The company expects to fund liquidity needs over the next 12 months through cash from operations, available cash, and its revolving credit facility. Key strategic priorities include integrating recent acquisitions (MTI and ISP) and expanding operational capabilities. The company is also working to remediate material weaknesses in internal controls as it transitions to public company reporting requirements. No significant changes in capital requirements are anticipated.
As of June 30, 2025, Karman held $27.4M in cash and equivalents, a $15.9M increase from year-end 2024, primarily from IPO proceeds and new borrowings. Total debt stood at $478.3M, comprising a $375.0M term note (net of $6.3M issuance costs), $30.0M drawn on the revolving credit facility, and $79.6M in finance lease liabilities. The new Citi Credit Agreement, entered in April 2025, replaced the previous TCW facilities and provides a $300M term loan (increased to $375M in May) and a $50M revolver. Shareholders' equity was $361.5M, reflecting the IPO conversion and subsequent acquisitions. The springing financial covenant (Consolidated First Lien Net Leverage Ratio ≤ 6.50x) was not yet tested as of June 30, 2025.
Remaining performance obligations (RPO) totaled $513.7M, representing future revenue from existing contracts. Management expects to recognize 38.6% of this in 2025, 34.0% in 2026, and the balance thereafter. Contract assets were $133.6M, up from $107.2M at year-end, while contract liabilities (deferred revenue) decreased to $19.9M. No material purchase commitments for inventory or capacity were disclosed.
Karman did not repurchase shares or pay dividends. Net debt increased as the company issued $405.0M in new term loan and revolver borrowings while repaying $363.8M (including the TCW term note and seller note). Capital expenditures totaled $8.7M for the six months, primarily for machinery and equipment. Acquisition spending was significant: $126.3M net cash used for MTI ($82.3M) and ISP ($58.6M), partially funded by equity issuance (147,842 shares valued at $5.8M) and an earnout liability ($3.9M).
The company operates as a single reportable segment. However, the notes disclose disaggregated revenue by end market for the three and six months: Hypersonics & Strategic Missile Defense ($65.0M, 30.2% of total), Space & Launch ($73.5M, 34.1%), and Tactical Missiles & Integrated Defense Systems ($76.7M, 35.7%). All three markets grew in H1 2025, with Tactical Missiles leading at +37.7% YoY. Substantially all customers are U.S.-based government or commercial entities. Customer concentration exists: three customers accounted for 23.2%, 12.6%, and 11.7% of revenue, and 45.9% of accounts receivable.
The provided excerpt does not contain the cash flow statement. It references capital expenditures in investing activities but does not provide the amount. Income tax provisions are mentioned but not cash flows. Therefore, no analysis can be performed.